Jaychem

What Jaychem does

Jaychem Industries Ltd is a privately held, family-owned Contract Development and Manufacturing Organisation (CDMO) headquartered in East Tamaki, Auckland, New Zealand. Founded in 1979 and now employing 51-100 staff, the firm operates the only New Zealand manufacturing facility holding combined Medsafe (NZ), TGA (Australia), ACVM (NZ veterinary) and APVMA (Australian veterinary) GMP approvals, giving it exclusive regulatory coverage for both human and animal health products within the domestic market.

The company offers an eight-module service stack spanning Contract R&D, GMP-certified Laboratory Services, Regulatory Affairs & Clinical Support, Product Development & Technology Transfer, Commercial-scale Manufacturing, Packaging & Labelling and Supply Chain management, terminating in finished-goods distribution. Core manufacturing capability is centred on non-sterile liquids, creams, gels, ointments and pastes, produced in ISO Class 8 / Grade D cleanrooms with batch sizes scalable from 100 to 5,000 L/kg, supported by high-shear mixers, vacuum emulsifiers, paddle stirrers and USP-grade purified water systems. Analytical capability includes validated HPLC methods, microbiological testing, preservative efficacy testing and a validated statistical modelling platform for stability data analysis per ICH Q1E; operations are backed by an integrated ERP system with a customer-facing portal providing real-time inventory, order tracking and production scheduling visibility.

Jaychem serves two primary business verticals: Human Health (OTC, prescription, nutraceutical, personal care and medical device products) and Animal Health (veterinary liquids, creams, gels and pastes for companion and production animals). It generates revenue through project-based professional service fees, manufacturing production fees and ongoing supply chain coordination services under quote-based pricing, with no publicly disclosed rates. It has executed over 100 product registrations across New Zealand, Australia, the EU, the United States, Canada and other regulated markets, and distributes both domestically and internationally via its own and customer forwarding agents.

Name

Jaychem

Legal name

Jaychem Industries Ltd

Website

https://jaychem.co.nz

Company type

Private

Founded year

1979

Operating status

Operating

Headcount range

11–50 employees

Short description

Jaychem is a privately held New Zealand CDMO founded in 1979 that contract develops and manufactures non-sterile human and animal health liquids, creams, gels, ointments and pastes for healthcare and wellness brand owners across NZ, AU, EU, US and Canada.

Ownership category

akta.pro rank

Product category

Contract Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

akta.pro secondary industries

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ)

Keywords

• Contract pharmaceutical manufacturing
• CDMO services
• Pharmaceutical formulation development
• GMP contract manufacturing
• Animal health manufacturing

Headquarters

HQ city

East Tamaki

HQ country

New Zealand

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Contract Development & Manufacturing Services: Full suite of CDMO services including formulation development, analytical testing, manufacturing, packaging, and supply chain management. Revenue is generated through project-based professional services fees, manufacturing production fees, and ongoing supply chain coordination services.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Jaychem is a New Zealand-based Contract Development and Manufacturing Organisation (CDMO) that provides end-to-end services from formulation development and analytical testing through commercial-scale GMP manufacturing, packaging, regulatory affairs, and supply chain management for non-sterile human and animal health products (liquids, creams, gels, ointments, and pastes). It operates the only Medsafe, TGA, ACVM, and APVMA approved manufacturing facility in New Zealand, supporting product registration across NZ, AU, EU, US, and Canada.

Product overview

Jaychem is a Contract Development & Manufacturing Organisation (CDMO) offering a unified platform of eight integrated services spanning the full product lifecycle from concept to commercialisation. The core CDMO service is supported by specialised modules: Contract Research & Development, Laboratory Services, Regulatory Affairs & Clinical Support, Product Development & Technology Transfer, Manufacturing Services, Packaging & Labelling, and Supply Chain management. The company operates two product verticals—Human Health (topical and oral liquids, creams, gels, ointments, and personal care) and Animal Health (veterinary liquids, creams, gels, and pastes for companion and production animals). All services are delivered through the company's GMP-licensed manufacturing facilities in Auckland, New Zealand, which are approved by Medsafe, TGA, and ACVM/APVMA, with cleanroom capabilities meeting ISO Class 8/Grade D standards.

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Development & Manufacturing Organisation (CDMO) Full-suite CDMO service providing end-to-end capabilities from early-stage formulation through to commercial manufacturing and global distribution for human and animal health products.
• Contract Research & Development End-to-end R&D support covering formulation development, dosage form and packaging design, stability studies, clinical trial preparation, and product optimization for human and animal health markets.
• Laboratory Services GMP-certified laboratory services including analytical and microbiological testing, method development and validation, impurity identification, stability studies, bulk hold studies, preservative efficacy testing, and elemental impurity risk assessment.
• Regulatory Affairs & Clinical Support In-house regulatory affairs team managing market assessment, regulatory strategy, document preparation and submission, label and packaging compliance, and ongoing compliance management across NZ, AU, EU, US, Canada and other markets.
• Product Development & Technology Transfer Technology transfer service ensuring smooth transition of novel to generic products into Jaychem's facility with technical review, process adaptation, equipment qualification, packaging compliance, process validation, and regulatory variation support.
• Manufacturing Services Commercial-scale GMP-compliant manufacturing for non-sterile human and animal health products including liquid and semi-solid production with batch sizes from 100 to 5,000 L/kg, supported by ISO Class 8/Grade D cleanrooms and USP-grade purified water systems.
• Packaging & Labelling GMP-compliant packaging and labelling services handling diverse formats including bottles, pots, tubes, pouches, syringes, and jerry cans, with filling, sealing, cartoning, coding, and anti-counterfeit technology options.
• Supply Chain End-to-end supply chain management covering procurement and sourcing of APIs, excipients, and packaging materials, secure warehousing, real-time inventory visibility via customer dashboard, distribution, and order and production tracking.

Quantifiable outcome

• Over 100 human and animal medicines successfully registered in multiple markets
• +3 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• NovaCina: Australia-based sterile injectable CDMO with strong animal health focus, offering liquid and semi-solid manufacturing for human and veterinary markets. Comparable dual human/animal health exposure across similar regulated geographies.
• Ego Pharmaceuticals: Australia-based contract manufacturer and brand owner specializing in dermatological creams, ointments and topical liquids. Directly comparable semi-solid CDMO capability with TGA approval serving similar OTC and personal care brands.
• Douglas Pharmaceuticals: NZ-based pharmaceutical contract manufacturer with GMP facilities producing generics and OTC medicines for human health. Direct ANZ competitor serving similar brand customers with comparable dosage form capabilities.
• IDT Australia: Australia-based specialty pharmaceutical manufacturer offering contract manufacturing of sterile and non-sterile dose forms with TGA approval. Comparable regional CDMO serving human health brands across similar dosage forms.

Broad incumbents

• Recipharm: European-headquartered CDMO providing integrated development, manufacturing and supply of pharmaceuticals across diverse dosage forms. Comparable end-to-end CDMO model though at much larger scale and broader geographic footprint.
• Eurofins CDMO: Global CDMO network offering API and drug product development and manufacturing across multiple dosage forms and geographies. Represents scale competition for ANZ brand owners seeking outsourced manufacturing.
• Aspen Pharmacare: South African-headquartered global pharmaceutical manufacturer with strong ANZ presence post-AstraZeneca acquisition. Comparable ANZ manufacturing footprint with TGA approval for branded and generic pharmaceuticals.
• Catalent: Global CDMO leader offering development and manufacturing across oral, sterile, biologic and inhalation dosage forms. Represents the large-scale incumbent competitor that brand owners may choose over regional CDMOs like Jaychem.

Regional players

• Aft Pharmaceuticals: NZ-based specialty pharmaceutical company with in-house manufacturing and licensing partnerships across ANZ. Comparable NZ origin and ANZ regulatory orientation, though more brand-led than pure CDMO.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jaychem